Live Breaking News & Updates on Finally Start Making

The demand for biologic drugs continues to grow at a steady 12–14% annually. To keep up, biotech and biopharma developers are increasingly relying on outsourcing partners to meet both clinical and commercial research, development, and production needs. ....

United States , San Antonio , South Korea , Samsung Biologics , Matej Macak , Navraj Nagra , Erwin Idoux , Eithne Walsh , Sandoz Novartis , Erika Stanzl , Mckinsey Co , Biologics Services , Scorpion Biological Services , Straits Research , Bioprocess International , European Union , Bioplan Associates , Scorpius Biomanufacturing , Strong Growth , Biologics Market , Antibodies Still Predominant , Finally Start Making , Cell Culture , Greater Efficiency , Capacity Concerns , North America ,